Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 15

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 15
---
 in the December 2023 Private Placement and (ii) the maximum
number of Ordinary Shares upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as
of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading
day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement,
without regard to any limitations on the exercise of the warrants.

Under the terms of the warrants,
a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its
affiliates and attribution parties, to beneficially own a number of Ordinary Shares which would exceed 4.99% or 9.99%, as applicable,
of our then outstanding Ordinary Shares following such exercise, excluding for purposes of such determination Ordinary Shares issuable
upon exercise of such warrants which have not been exercised. The beneficial ownership limitation may be increased or decreased, provided
that in no event shall it exceed 9.99%, upon notice to us, provided that any increase in the beneficial ownership limitation shall not
be effective until 61 days following the receipt of such notice by us. The number of shares in the table below does not reflect this
limitation. See “Plan of Distribution.” The selling shareholders may sell all, some or none of their Ordinary Shares
in this offering. See “Plan of Distribution.”

| Name of Selling Shareholder     |     | Number of Ordinary    
 Shares Owned Prior to 
 Offering              |             |     | Maximum Number of             
 Ordinary Shares to be Sold    
 Pursuant to this Prospectus * |            |     | Number of Ordinary 
 Shares Owned After 
 Offering (1)       |             |
| Bigger Capital Fund, LP (2)*    |     |                       | 468,000,000 |     |                               | 81,100,000 |     |                    | 386,900,000 |
| District 2 Capital Fund LP (3)* |     |                       | 484,500,000 |     |                               | 90,600,000 |     |                    | 393,900,000 |

________________

*Subject to beneficial ownership blocker of 9.99%.

| (1) | Assumes that all Ordinary Shares                                                             
 being registered under the registration statement of which this prospectus forms a part are  
 sold in this offering, and that none of the selling stockholders acquire additional Ordinary 
 Shares after the date of this prospect